Patents by Inventor Anuska Llano

Anuska Llano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
    Patent number: 11919926
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: March 5, 2024
    Assignees: ESTEVE PHARMACEUTICALS, S.A., FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising gag, pol, vif and nef epitopes
    Patent number: 11325946
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: May 10, 2022
    Assignees: LABORATORIOS DEL DR. ESTEVE S.A., FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDE—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20210246172
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 12, 2021
    Inventors: Christian BRANDER, Beatriz Mothe PUJADAS, Anuska LLANO
  • Immunogens for HIV vaccination
    Patent number: 10815278
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: October 27, 2020
    Assignees: Laboratorios del Dr. Esteve S.A., Fundació Privada Institut de Recerca de La Sida—Caixa
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20190055289
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: May 3, 2018
    Publication date: February 21, 2019
    Inventors: Christian BRANDER, Beatriz MOTHE PUJADAS, Anuska LLANO
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20180170971
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: September 28, 2017
    Publication date: June 21, 2018
    Inventors: Christian BRANDER, Beatriz MOTHE PUJADAS, Anuska LLANO
  • Immunogens for HIV vaccination
    Patent number: 9988425
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: June 5, 2018
    Assignees: Laboratories Del Dr. Esteve S.A., Fundació Privada Institut De Recerca De La Sida—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20150050310
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.
    Type: Application
    Filed: January 28, 2013
    Publication date: February 19, 2015
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano